Results 71 to 80 of about 416,692 (196)
Vaccines against cholera, typhoid fever and shigellosis for developing countries.
, 2004 Enteric diseases, such as cholera, typhoid fever and shigellosis, still produce a significant burden, especially among the poor in countries where these illnesses are endemic.
Ochiai, RL +7 more
core +1 more source
Development of Hillchol (R), a low-cost inactivated single strain Hikojima oral cholera vaccine
, 2020 Cholera remains an important global health problem with up to 4 million cases and 140,000 deaths annually. Oral cholera vaccines (OCVs) are now a cornerstone of the WHOs "Ending Cholera - A Global Roadmap to 2030" global program for the eventual ...
Ahasan, M. M. +14 more
core +1 more source
Oral cholera vaccine development and use in Vietnam.
, 2014 Oral Cholera Vaccine Development and Use in ...
Jacqueline L. Deen (148731) +26 more
core +1 more source
Cholera vaccine : what you need to know [PDF]
Cholera is a disease that can cause severe diarrheaand vomiting. If it isn\u2019t treated quickly, it can lead to dehydration and even death. About 100,000-130,000 people are thought to die from cholera each year, almost all of them in countries where ...
core +2 more sources
History of the development of oral cholera vaccine in Vietnam.
, 2014 History of the development of oral cholera vaccine in Vietnam.
Dang Duc Anh (232106) +8 more
core +1 more source
BMC Infectious Diseases, 2017 Background Cholera is a diarrheal disease that produces rapid dehydration. The infection is a significant cause of mortality and morbidity. Oral cholera vaccine (OCV) has been propagated for the prevention of cholera.
Patrick G. Ilboudo +1 more
doaj +1 more source
Kazan medical journal, 1909 Preparing for the encounter of such an enemy as cholera, which took away in one past century about two million inhabitants of Russia (Erisman), you involuntarily strive to sum up the exact results of modern methods of fighting the infection, you involuntarily unfold pages full of either brilliant victories or bitter ones.
openaire +1 more source
PLoS Medicine, 2019 BACKGROUND:Cholera causes an estimated 100,000 deaths annually worldwide, with the majority of burden reported in sub-Saharan Africa. In May 2018, the World Health Assembly committed to reducing worldwide cholera deaths by 90% by 2030.
Elizabeth C Lee +5 more
doaj +1 more source
, 2020 Antibody avidity is an important measure of the quality of vaccine-induced immune responses. Murine and human studies suggest that antibody avidity may be augmented by limiting access to antigen.
Mottram, Lynda, +3 more
core +1 more source
, 2019 Young children, older children, and adults develop comparable levels and durations of immunity following cholera. In comparison, young children receiving oral killed cholera vaccines (OCV) develop a lower level and shorter duration of protection than ...
Rashu, Rasheduzzaman +17 more
core +1 more source